Financial Snapshot

Revenue
$8.594M
TTM
Gross Margin
79.13%
TTM
Net Earnings
-$17.07M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
71.39%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
$20.88M
Q3 2024
Book Value
$3.183M
Q3 2024
Cash
Q3 2024
P/E
-1.501
Nov 29, 2024 EST
Free Cash Flow
-$15.13M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $8.548M $19.28M $13.98M $30.11M $25.07M $15.28M $12.50M $14.03M $19.12M $19.40M $15.33M $53.07M $33.49M $31.59M $24.46M $28.54M $35.64M $22.32M $28.57M $13.85M $11.84M $7.190M $6.520M $3.160M $90.00K $0.00
YoY Change -55.67% 37.96% -53.58% 20.09% 64.15% 22.2% -10.87% -26.66% -1.43% 26.59% -71.12% 58.48% 6.01% 29.15% -14.3% -19.92% 59.68% -21.88% 106.28% 16.98% 64.67% 10.28% 106.33% 3411.11%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $8.548M $19.28M $13.98M $30.11M $25.07M $15.28M $12.50M $14.03M $19.12M $19.40M $15.33M $53.07M $33.49M $31.59M $24.46M $28.54M $35.64M $22.32M $28.57M $13.85M $11.84M $7.190M $6.520M $3.160M $90.00K $0.00
Cost Of Revenue $1.717M $1.588M $1.955M $1.406M $1.263M $1.640M $6.633M $5.290M $3.905M $5.686M $4.837M $4.654M $4.713M $4.280M $5.310M $3.370M $3.230M $3.250M $2.820M $2.730M $2.430M $3.090M $3.250M $1.880M $40.00K $0.00
Gross Profit $6.831M $17.70M $12.02M $28.71M $23.81M $13.64M $5.867M $8.735M $15.22M $13.72M $10.49M $48.42M $28.77M $27.32M $19.15M $25.17M $32.41M $19.07M $25.75M $11.12M $9.410M $4.100M $3.270M $1.280M $50.00K $0.00
Gross Profit Margin 79.91% 91.76% 86.01% 95.33% 94.96% 89.26% 46.94% 62.28% 79.58% 70.69% 68.44% 91.23% 85.93% 86.48% 78.29% 88.19% 90.94% 85.44% 90.13% 80.29% 79.48% 57.02% 50.15% 40.51% 55.56%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Selling, General & Admin $14.36M $15.92M $14.45M $13.61M $14.12M $12.26M $13.17M $11.83M $11.57M $12.28M $12.71M $12.10M $13.57M $14.94M $15.02M $15.51M $13.65M $12.84M $11.03M $9.790M $8.400M $12.17M $12.23M $9.920M $2.970M $730.0K
YoY Change -9.75% 10.15% 6.16% -3.57% 15.11% -6.86% 11.33% 2.24% -5.85% -3.32% 5.05% -10.9% -9.12% -0.55% -3.16% 13.63% 6.31% 16.41% 12.67% 16.55% -30.98% -0.49% 23.29% 234.01% 306.85%
% of Gross Profit 210.28% 89.94% 120.19% 47.42% 59.28% 89.93% 224.39% 135.37% 76.0% 89.57% 121.14% 24.98% 47.17% 54.67% 78.43% 61.62% 42.12% 67.33% 42.83% 88.04% 89.27% 296.83% 374.01% 775.0% 5940.0%
Research & Development $29.35M $36.86M $31.85M $27.71M $29.64M $25.01M $31.61M $29.27M $24.32M $22.43M $18.95M $20.27M $34.05M $36.21M $34.80M $40.85M $43.30M $37.67M $29.14M $24.39M $20.95M $29.55M $24.57M $13.34M $6.360M $710.0K
YoY Change -20.38% 15.75% 14.93% -6.51% 18.5% -20.87% 7.98% 20.38% 8.42% 18.39% -6.51% -40.49% -5.96% 4.05% -14.81% -5.66% 14.95% 29.27% 19.48% 16.42% -29.1% 20.27% 84.18% 109.75% 795.77%
% of Gross Profit 429.67% 208.32% 264.9% 96.53% 124.48% 183.45% 538.76% 335.13% 159.78% 163.54% 180.62% 41.86% 118.35% 132.54% 181.72% 162.3% 133.6% 197.54% 113.17% 219.33% 222.64% 720.73% 751.38% 1042.19% 12720.0%
Depreciation & Amortization $31.00K $119.0K $288.0K $297.0K $291.0K $254.0K $437.0K $416.0K $425.0K $601.0K $558.0K $964.0K $1.176M $2.250M $2.510M $2.630M $2.320M $2.460M $3.170M $4.640M $4.740M $4.320M $3.290M $1.500M $310.0K $10.00K
YoY Change -73.95% -58.68% -3.03% 2.06% 14.57% -41.88% 5.05% -2.12% -29.28% 7.71% -42.12% -18.03% -47.73% -10.36% -4.56% 13.36% -5.69% -22.4% -31.68% -2.11% 9.72% 31.31% 119.33% 383.87% 3000.0%
% of Gross Profit 0.45% 0.67% 2.4% 1.03% 1.22% 1.86% 7.45% 4.76% 2.79% 4.38% 5.32% 1.99% 4.09% 8.24% 13.11% 10.45% 7.16% 12.9% 12.31% 41.73% 50.37% 105.37% 100.61% 117.19% 620.0%
Operating Expenses $43.72M $52.78M $46.30M $41.32M $43.76M $37.28M $44.77M $41.10M $35.88M $34.71M $31.65M $32.36M $47.63M $14.94M $49.82M $56.35M $56.95M $50.50M $41.38M $35.43M $30.68M $43.06M $38.65M $24.10M $9.410M $1.440M
YoY Change -17.17% 14.0% 12.04% -5.57% 17.38% -16.75% 8.94% 14.54% 3.37% 9.67% -2.19% -32.06% 218.85% -70.02% -11.59% -1.05% 12.77% 22.04% 16.79% 15.48% -28.75% 11.41% 60.37% 156.11% 553.47%
Operating Profit -$36.88M -$35.08M -$34.27M -$12.62M -$19.94M -$23.64M -$2.237M -$32.36M -$20.66M -$21.00M -$21.16M $16.06M -$18.85M $12.38M -$30.67M -$31.18M -$24.54M -$31.43M -$15.63M -$24.31M -$21.27M -$38.96M -$35.38M -$22.82M -$9.360M -$1.440M
YoY Change 5.14% 2.36% 171.68% -36.75% -15.63% 956.77% -93.09% 56.62% -1.59% -0.77% -231.8% -185.16% -252.25% -140.37% -1.64% 27.06% -21.92% 101.09% -35.71% 14.29% -45.41% 10.12% 55.04% 143.8% 550.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Interest Expense -$663.0K $2.399M $2.148M $2.237M $2.501M $2.573M $2.425M $2.288M $2.236M $1.151M $6.000K $7.000K $5.000K $940.0K $380.0K $760.0K $920.0K $400.0K -$2.090M -$3.310M -$1.420M $1.800M $4.470M $2.970M $650.0K $120.0K
YoY Change -127.64% 11.69% -3.98% -10.56% -2.8% 6.1% 5.99% 2.33% 94.27% 19083.33% -14.29% 40.0% -99.47% 147.37% -50.0% -17.39% 130.0% -119.14% -36.86% 133.1% -178.89% -59.73% 50.51% 356.92% 441.67%
% of Operating Profit 0.04% 7.59%
Other Income/Expense, Net $9.923M -$251.0K -$1.992M -$1.720M -$1.427M -$1.703M -$1.458M -$2.145M -$1.999M -$1.112M -$290.0K $144.0K $88.00K
YoY Change -4053.39% -87.4% 15.81% 20.53% -16.21% 16.8% -32.03% 7.3% 79.77% 283.45% -301.39% 63.64%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Pretax Income -$27.62M -$35.33M -$36.27M -$14.34M -$21.37M -$25.34M -$3.700M -$34.51M -$22.66M -$22.11M -$21.45M $16.20M -$18.77M -$22.90M -$30.29M -$43.91M -$24.34M -$33.33M -$18.12M -$27.62M -$22.70M -$37.17M -$44.93M -$19.85M -$8.710M -$1.320M
YoY Change -21.82% -2.57% 152.89% -32.9% -15.67% 584.86% -89.28% 52.29% 2.49% 3.08% -232.41% -186.31% -18.03% -24.4% -31.02% 80.4% -26.97% 83.94% -34.4% 21.67% -38.93% -17.27% 126.35% 127.9% 559.85%
Income Tax $0.00 $0.00 $0.00 -$150.0K $0.00 $53.00K $24.00K $320.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $20.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$27.62M -$35.33M -$36.27M -$582.0K -$20.58M -$25.32M -$3.695M -$34.51M -$22.66M -$22.11M -$21.45M $16.20M -$18.77M -$22.90M -$30.29M -$43.91M -$24.34M -$33.33M -$18.13M -$27.64M -$22.70M -$37.17M -$44.93M -$19.85M -$8.710M -$1.320M
YoY Change -21.82% -2.57% 6131.1% -97.17% -18.73% 585.3% -89.29% 52.27% 2.5% 3.07% -232.42% -186.33% -18.06% -24.4% -31.02% 80.4% -26.97% 83.84% -34.41% 21.76% -38.93% -17.27% 126.35% 127.9% 559.85%
Net Earnings / Revenue -323.16% -183.23% -259.46% -1.93% -82.07% -165.77% -29.56% -246.05% -118.51% -113.96% -139.97% 30.53% -56.04% -72.49% -123.83% -153.85% -68.29% -149.33% -63.46% -199.57% -191.72% -516.97% -689.11% -628.16% -9677.78%
Basic Earnings Per Share -$1.05 -$1.55 -$0.16 $0.00 -$0.12 -$0.16 -$0.03 -$0.26 -$0.19 -$0.20 -$0.21 $0.18 -$0.21
Diluted Earnings Per Share -$1.05 -$1.55 -$0.16 $0.00 -$0.12 -$0.16 -$0.03 -$0.26 -$0.19 -$0.20 -$0.21 $0.18 -$0.21 -$263.6K -$363.1K -$560.6K -$345.3K -$505.3K -$337.5K -$536.6K -$449.4K -$769.2K -$968.1K -$1.159M -$1.647M -$360.7K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Cash & Short-Term Investments $29.68M $43.48M $69.81M $40.70M $64.70M $34.30M $36.80M $25.00M $29.00M $32.70M $20.60M $28.50M $28.40M $45.40M $41.10M $50.30M $57.30M $69.90M $83.60M $41.80M $60.70M $42.80M $55.20M $104.4M $16.60M $8.000M
YoY Change -31.74% -37.71% 71.52% -37.09% 88.63% -6.79% 47.2% -13.79% -11.31% 58.74% -27.72% 0.35% -37.44% 10.46% -18.29% -12.22% -18.03% -16.39% 100.0% -31.14% 41.82% -22.46% -47.13% 528.92% 107.5%
Cash & Equivalents $28.40M $43.48M $49.84M $21.30M $34.90M $31.60M $29.40M $5.400M $3.600M $2.700M $7.800M $11.20M $8.900M $10.40M $8.300M $29.40M $37.60M $41.60M $65.50M $20.00M $21.20M $14.10M $12.60M $46.70M $3.900M $8.000M
Short-Term Investments $1.280M $0.00 $19.97M $19.40M $29.80M $2.700M $7.400M $19.60M $25.50M $30.00M $12.80M $17.30M $19.50M $35.00M $32.80M $20.80M $19.70M $28.30M $18.00M $21.80M $39.50M $28.70M $42.60M $57.70M $12.70M $0.00
Other Short-Term Assets $1.511M $2.375M $3.580M $19.50M $1.500M $2.200M $3.100M $2.500M $3.100M $1.000M $1.900M $2.300M $2.200M $2.900M $1.400M $2.500M $1.900M $1.700M $4.000M $1.400M $1.500M $1.600M $2.300M $900.0K $600.0K $100.0K
YoY Change -36.38% -33.66% -81.64% 1200.0% -31.82% -29.03% 24.0% -19.35% 210.0% -47.37% -17.39% 4.55% -24.14% 107.14% -44.0% 31.58% 11.76% -57.5% 185.71% -6.67% -6.25% -30.43% 155.56% 50.0% 500.0%
Inventory $2.219M $2.113M $1.870M $1.900M $3.400M $3.400M $3.200M $3.800M $3.900M $3.600M $3.500M $3.400M $3.300M $2.800M $2.800M $3.500M $2.000M $2.100M $2.000M $1.900M $1.900M $1.700M $1.900M $2.700M $200.0K $0.00
Prepaid Expenses
Receivables $1.261M $3.423M $6.477M $900.0K $2.300M $1.800M $2.400M $1.200M $2.200M $2.100M $2.300M $2.200M $3.400M $3.700M $1.700M $4.100M $3.600M $2.200M $4.500M $2.500M $2.000M $900.0K $800.0K $1.300M $100.0K $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $34.67M $51.39M $81.74M $63.10M $71.80M $41.70M $45.40M $32.40M $38.30M $39.50M $28.30M $36.40M $37.30M $54.80M $47.10M $60.30M $64.80M $75.80M $94.10M $47.60M $66.10M $47.00M $60.20M $109.3M $17.50M $8.100M
YoY Change -32.54% -37.12% 29.54% -12.12% 72.18% -8.15% 40.12% -15.4% -3.04% 39.58% -22.25% -2.41% -31.93% 16.35% -21.89% -6.94% -14.51% -19.45% 97.69% -27.99% 40.64% -21.93% -44.92% 524.57% 116.05%
Property, Plant & Equipment $4.071M $2.131M $3.673M $5.000M $6.500M $600.0K $900.0K $1.300M $1.600M $1.700M $2.000M $2.500M $3.100M $1.800M $3.800M $6.000M $7.700M $7.500M $7.300M $7.100M $9.300M $11.60M $13.10M $4.500M $1.300M $200.0K
YoY Change 91.04% -41.98% -26.54% -23.08% 983.33% -33.33% -30.77% -18.75% -5.88% -15.0% -20.0% -19.35% 72.22% -52.63% -36.67% -22.08% 2.67% 2.74% 2.82% -23.66% -19.83% -11.45% 191.11% 246.15% 550.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $1.000M $0.00 $1.800M $3.400M $0.00 $1.500M $3.200M $0.00 $1.400M $3.700M $10.50M $5.500M $17.20M $21.30M $2.600M $18.00M $1.700M $2.300M $0.00
YoY Change -100.0% -100.0% -47.06% -100.0% -53.13% -100.0% -62.16% -64.76% 90.91% -68.02% -19.25% 719.23% -85.56% 958.82% -26.09%
Other Assets $278.0K $406.0K $411.0K $400.0K $1.300M $1.300M $400.0K $400.0K $500.0K $600.0K $700.0K $700.0K $800.0K $1.300M $800.0K $700.0K $1.300M $2.300M $3.600M $5.400M $6.300M $2.900M $3.400M $0.00
YoY Change -31.53% -1.22% 2.75% -69.23% 0.0% 225.0% 0.0% -20.0% -16.67% -14.29% 0.0% -12.5% -38.46% 62.5% 14.29% -46.15% -43.48% -36.11% -33.33% -14.29% 117.24% -14.71%
Total Long-Term Assets $10.52M $8.706M $10.25M $12.50M $14.20M $8.300M $7.700M $8.100M $8.500M $10.60M $12.50M $9.500M $11.90M $12.80M $11.10M $14.60M $19.20M $26.70M $23.30M $37.90M $46.30M $26.00M $44.70M $11.30M $5.000M $200.0K
YoY Change 20.81% -15.09% -17.98% -11.97% 71.08% 7.79% -4.94% -4.71% -19.81% -15.2% 31.58% -20.17% -7.03% 15.32% -23.97% -23.96% -28.09% 14.59% -38.52% -18.14% 78.08% -41.83% 295.58% 126.0% 2400.0%
Total Assets $45.19M $60.10M $91.99M $75.60M $86.00M $50.00M $53.10M $40.50M $46.80M $50.10M $40.80M $45.90M $49.20M $67.60M $58.20M $74.90M $84.00M $102.5M $117.4M $85.50M $112.4M $73.00M $104.9M $120.6M $22.50M $8.300M
YoY Change
Accounts Payable $1.777M $3.106M $1.311M $1.700M $2.100M $1.600M $1.500M $2.100M $1.300M $1.000M $700.0K $1.800M $1.300M $1.000M $1.000M $1.000M $1.800M $900.0K $1.800M $1.700M $600.0K $400.0K $2.000M $700.0K $500.0K $100.0K
YoY Change -42.79% 136.92% -22.88% -19.05% 31.25% 6.67% -28.57% 61.54% 30.0% 42.86% -61.11% 38.46% 30.0% 0.0% 0.0% -44.44% 100.0% -50.0% 5.88% 183.33% 50.0% -80.0% 185.71% 40.0% 400.0%
Accrued Expenses $5.769M $7.762M $8.550M $7.600M $8.300M $4.700M $5.500M $5.100M $5.000M $5.100M $5.900M $4.000M $4.900M $6.500M $5.300M $5.200M $5.500M $4.500M $3.900M $2.500M $2.600M $2.100M $2.400M $2.900M $800.0K $400.0K
YoY Change -25.68% -9.22% 12.5% -8.43% 76.6% -14.55% 7.84% 2.0% -1.96% -13.56% 47.5% -18.37% -24.62% 22.64% 1.92% -5.45% 22.22% 15.38% 56.0% -3.85% 23.81% -12.5% -17.24% 262.5% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $16.66M $21.17M $0.00 $900.0K $0.00 $7.300M $19.90M $0.00 $23.60M $200.0K $200.0K $500.0K $500.0K $600.0K $700.0K $400.0K $100.0K $0.00
YoY Change -21.29% -100.0% -100.0% -63.32% -100.0% 11700.0% 0.0% -60.0% 0.0% -16.67% -14.29% 75.0% 300.0%
Total Short-Term Liabilities $27.01M $34.00M $10.06M $10.70M $36.80M $7.700M $15.80M $28.80M $7.400M $7.000M $7.200M $6.900M $14.90M $17.90M $12.30M $16.90M $39.10M $12.70M $9.900M $5.500M $5.000M $5.200M $5.700M $4.300M $1.500M $500.0K
YoY Change -20.57% 238.15% -6.02% -70.92% 377.92% -51.27% -45.14% 289.19% 5.71% -2.78% 4.35% -53.69% -16.76% 45.53% -27.22% -56.78% 207.87% 28.28% 80.0% 10.0% -3.85% -8.77% 32.56% 186.67% 200.0%
Long-Term Debt $0.00 $0.00 $20.63M $19.90M $20.30M $20.50M $12.60M $0.00 $19.70M $19.80M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $37.90M $58.00M $60.90M $61.40M $1.400M $2.000M $1.100M $200.0K $100.0K
YoY Change -100.0% 3.68% -1.97% -0.98% 62.7% -100.0% -0.51% -100.0% -34.66% -4.76% -0.81% 4285.71% -30.0% 81.82% 450.0% 100.0%
Other Long-Term Liabilities $3.395M $1.111M $3.520M $4.900M $6.100M $1.800M $3.200M $3.400M $4.800M $4.800M $2.900M $2.700M $30.80M $35.20M $18.10M $20.40M $10.40M $14.80M $6.100M $700.0K $900.0K $200.0K $200.0K $0.00 $0.00
YoY Change 205.58% -68.44% -28.16% -19.67% 238.89% -43.75% -5.88% -29.17% 0.0% 65.52% 7.41% -91.23% -12.5% 94.48% -11.27% 96.15% -29.73% 142.62% 771.43% -22.22% 350.0% 0.0%
Total Long-Term Liabilities $3.395M $1.111M $24.15M $24.80M $26.40M $22.30M $15.80M $3.400M $24.50M $24.60M $2.900M $2.700M $30.80M $35.20M $18.10M $20.40M $10.40M $52.70M $64.10M $61.60M $62.30M $1.600M $2.200M $1.100M $200.0K $100.0K
YoY Change 205.58% -95.4% -2.61% -6.06% 18.39% 41.14% 364.71% -86.12% -0.41% 748.28% 7.41% -91.23% -12.5% 94.48% -11.27% 96.15% -80.27% -17.78% 4.06% -1.12% 3793.75% -27.27% 100.0% 450.0% 100.0%
Total Liabilities $30.41M $35.12M $34.21M $35.50M $63.20M $30.00M $31.60M $32.20M $31.90M $31.60M $10.10M $9.600M $45.70M $53.10M $30.30M $37.30M $49.40M $65.50M $74.10M $67.10M $67.30M $6.800M $7.900M $5.400M $1.700M $500.0K
YoY Change -13.41% 2.65% -3.64% -43.83% 110.67% -5.06% -1.86% 0.94% 0.95% 212.87% 5.21% -78.99% -13.94% 75.25% -18.77% -24.49% -24.58% -11.61% 10.43% -0.3% 889.71% -13.92% 46.3% 217.65% 240.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Basic Shares Outstanding 26.26M 22.78M 225.0M 199.5M 178.0M 159.8M 145.3M 133.2M 118.5M 111.7M 103.1M shares 88.43M shares 87.41M shares
Diluted Shares Outstanding 26.52M 22.78M 22.51M 19.95M 159.8M 145.3M 133.2M 118.5M 111.7M 103.1M shares 88.59M shares 87.41M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $25.619 Million

About DURECT CORP

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. The company is headquartered in Cupertino, California and currently employs 45 full-time employees. The company went IPO on 2000-09-28. Larsucosterol is in clinical development for the potential treatment of alcohol-associated hepatitis, for which United States Food and Drug Administration (FDA) has granted a Fast Track Designation; metabolic dysfunction-associated steatohepatitis is also being explored. Its commercial pharmaceutical products include POSIMIR (bupivacaine solution), PERSERIS (schizophrenia) and Methydur Sustained Release Capsules (ADHD). POSIMIR (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the SABER platform technology, is FDA-approved. Its ALZET product line consists of miniature, implantable osmotic pumps and accessories used for research in mice, rats and other laboratory animals.

Industry: Pharmaceutical Preparations Peers: Lyra Therapeutics, Inc. CorMedix Inc. Ikena Oncology, Inc. JOHNSON & JOHNSON MARIMED INC. Paratek Pharmaceuticals, Inc. scPharmaceuticals Inc. TFF Pharmaceuticals, Inc. Verrica Pharmaceuticals Inc.